<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Bavarian Nordic — Januar 2017]]></title><description><![CDATA[<p dir="auto">Spændende år og god start for de to selskaber. Begge er oppe med 2-3 %.</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/451931/bavarian-nordic-januar-2017</link><generator>RSS for Node</generator><lastBuildDate>Sat, 13 Jun 2026 17:01:11 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/451931.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 02 Jan 2017 10:42:56 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Mon, 30 Jan 2017 17:30:44 GMT]]></title><description><![CDATA[<p dir="auto">Er der nogen der ved hvornår vi får recept tal fra Zealand?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489910</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489910</guid><dc:creator><![CDATA[LeStrata]]></dc:creator><pubDate>Mon, 30 Jan 2017 17:30:44 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Fri, 27 Jan 2017 13:02:22 GMT]]></title><description><![CDATA[<p dir="auto">S<br />
orry, forkert tråd.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489905</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489905</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 27 Jan 2017 13:02:22 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Fri, 27 Jan 2017 13:01:40 GMT]]></title><description><![CDATA[<p dir="auto">@E L: TA<br />
, tabermetode.. who gives a f...?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489909</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489909</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 27 Jan 2017 13:01:40 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Fri, 27 Jan 2017 12:30:44 GMT]]></title><description><![CDATA[<p dir="auto">Nemlig, nik <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=de222e39001" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489904</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489904</guid><dc:creator><![CDATA[kkjoel]]></dc:creator><pubDate>Fri, 27 Jan 2017 12:30:44 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Fri, 27 Jan 2017 10:06:55 GMT]]></title><description><![CDATA[<p dir="auto">de må shorte alt hvad de har lyst til, men det fundementale vil vinde på den lange bane.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489903</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489903</guid><dc:creator><![CDATA[nik_hs1990]]></dc:creator><pubDate>Fri, 27 Jan 2017 10:06:55 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Fri, 27 Jan 2017 10:06:34 GMT]]></title><description><![CDATA[<p dir="auto">mine Bava ligger i hvert fald trygt i depotet.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489907</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489907</guid><dc:creator><![CDATA[nik_hs1990]]></dc:creator><pubDate>Fri, 27 Jan 2017 10:06:34 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Thu, 26 Jan 2017 18:00:18 GMT]]></title><description><![CDATA[<p dir="auto">Rolig OHW - det kan de ikke, men det er spændende at se, hvor længe, de kan holde den nede. Firmaet er da stærkere nu, end det var, da kursen var tæt på 400.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489908</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489908</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Thu, 26 Jan 2017 18:00:18 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Thu, 26 Jan 2017 13:11:05 GMT]]></title><description><![CDATA[<p dir="auto">Øv havde meget tro på Bava, men den bliver shortet ihjel.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489906</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489906</guid><dc:creator><![CDATA[OHW]]></dc:creator><pubDate>Thu, 26 Jan 2017 13:11:05 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 21:02:59 GMT]]></title><description><![CDATA[<p dir="auto">Sanofis tilbud gælder på den del af beløbet som ikke dækkes af forsikringen. Hvorvidt Zealand Pharma får betalt deres royalty af det samlede beløb eller den del som forsikringen betaler er ikke noget hverken Sanofi eller Zealand Pharma har meldt noget ud om.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489899</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489899</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 21:02:59 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 20:56:20 GMT]]></title><description><![CDATA[<p dir="auto">Netop bb.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489900</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489900</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 20:56:20 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:07:59 GMT]]></title><description><![CDATA[<p dir="auto">Disse nyheder har været ude siden 4. januar.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489897</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489897</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:07:59 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:07:15 GMT]]></title><description><![CDATA[<p dir="auto">program. Savings may vary depending on patient’s out-of-pocket costs. Upon registration, patient receives all program details. Sanofi US reserves the right to rescind, revoke, or amend the program without notice.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489901</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489901</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:07:15 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:07:00 GMT]]></title><description><![CDATA[<p dir="auto">** With the SOLIQUA 100/33 Savings Card, patients may be eligible for the $0 CO-PAY offer for the next 12 months. Restrictions apply. This offer is for commercially insured patients and is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, or TRICARE, or similar federal or state programs including any state pharmaceutical programs. Void where prohibited by law. Savings card carries maximum savings of $700 off per pack for the duration of the</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489898</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489898</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:07:00 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:06:25 GMT]]></title><description><![CDATA[<p dir="auto">Sanofi is offering Soliqua 100/33 at a $0 co-pay** for eligible U.S. patients with commercial insurance and is working to secure coverage for Soliqua 100/33 on health plans nationwide. Sanofi is also offering a tailored support program, Soliqua 100/33 COACH, at no cost to adults living with type 2 diabetes who have been prescribed Soliqua 100/33 by their doctor.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489902</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489902</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:06:25 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:05:58 GMT]]></title><description><![CDATA[<p dir="auto">The daily Wholesale Acquisition Cost (WAC) price of Soliqua 100/33 is $127 for a 300 Unit pen, which equals $19.90 per day at the average final dose of 47 Units used in the labeled clinical trial.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489893</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489893</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:05:58 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:05:36 GMT]]></title><description><![CDATA[<p dir="auto">I en pressemeddelse af 4. januar 2017 siger sanofi <a href="http://mediaroom.sanofi.com/sanofi-announces-soliqua-10033-now-available-in-the-u-s-%E2%80%8B/" rel="nofollow ugc">http://mediaroom.sanofi.com/sanofi-announces-soliqua-10033-now-available-in-the-u-s-​/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489892</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489892</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:05:36 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 18:04:46 GMT]]></title><description><![CDATA[<p dir="auto">Zealand får royalties af nettosalget. Nettosalg = listepris - rabat. Jeg kan ikke se at det skulle være anderledes, ellers skulle Zealand jo få royalties af det fulde beløb og det tror jeg ikke der er nogen analytikere der har regnet med. I mine øjne er der absolut intet nyt i det Novod har sagt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489891</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489891</guid><dc:creator><![CDATA[bb]]></dc:creator><pubDate>Wed, 25 Jan 2017 18:04:46 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 15:39:25 GMT]]></title><description><![CDATA[<p dir="auto">Den situation tackler Novo og Sanofi hver for sig ud fra deres egne forudsætninger.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489890</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489890</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 15:39:25 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 15:38:20 GMT]]></title><description><![CDATA[<p dir="auto">Netop.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489889</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489889</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 15:38:20 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 15:37:04 GMT]]></title><description><![CDATA[<p dir="auto">Er problemet ganske enkelt ikke bare, at LLY med Basaglar lægger et voldsomt pres på marginerne, i både Novo og Sanofi?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489886</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489886</guid><dc:creator><![CDATA[rex_pacis]]></dc:creator><pubDate>Wed, 25 Jan 2017 15:37:04 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 12:41:17 GMT]]></title><description><![CDATA[<p dir="auto">Helge, det lyder spændende. Kan du ikke spørge din kontakt om de kun vælger at markedsføre Soliqua eller både Soliqua/Adlyxin i US?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489885</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489885</guid><dc:creator><![CDATA[KRANEN1]]></dc:creator><pubDate>Wed, 25 Jan 2017 12:41:17 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 12:12:20 GMT]]></title><description><![CDATA[<p dir="auto">Både min kontakt og jeg blev for tidsmæssigt presset mandag. Jeg sender derfor min spørgsmål til hende på mail i dag eller morgen.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489894</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489894</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 12:12:20 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 12:01:39 GMT]]></title><description><![CDATA[<p dir="auto">Helge, hvordan gik dit møde hos Sanofi under dit ophold i Paris, blev du overhovedet lukket ind........</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489887</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489887</guid><dc:creator><![CDATA[Mullefar]]></dc:creator><pubDate>Wed, 25 Jan 2017 12:01:39 GMT</pubDate></item><item><title><![CDATA[Reply to Bavarian Nordic — Januar 2017 on Wed, 25 Jan 2017 11:56:51 GMT]]></title><description><![CDATA[<p dir="auto">Kommenterer på Børsen Play i morgen på den komplekse situation.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10489884</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10489884</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 Jan 2017 11:56:51 GMT</pubDate></item></channel></rss>